TANYA MONAGHAN Tanya.Monaghan@nottingham.ac.uk
Clinical Associate Professor in Luminal Gastroenterology
Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in bile acid-farnesoid X receptor-fibroblast growth factor pathway
Monaghan, Tanya M.; Mullish, Benjamin H.; Patterson, Jordan; Wong, Gane K.S.; Marchesi, Julian R.; Xu, Huiping; Tahseen, Jilani; Kao, Dina
Authors
Benjamin H. Mullish
Jordan Patterson
Gane K.S. Wong
Julian R. Marchesi
Huiping Xu
Jilani Tahseen
Dina Kao
Abstract
The mechanisms of efficacy for fecal microbiota# transplantation (FMT) in treating recurrent Clostridioides difficile infection (rCDI) remain poorly defined, with restored gut microbiota-bile acid interactions representing one possible explanation. Furthermore, the potential implications for host physiology of these FMT-related changes in gut bile acid metabolism are also not well explored. In this study, we investigated the impact of FMT for rCDI upon signalling through the farnesoid X receptor (FXR)-fibroblast growth factor (FGF) pathway. Herein, we identify that in addition to restoration of gut microbiota and bile acid profiles, FMT for rCDI is accompanied by a significant, sustained increase in circulating levels of FGF19 and reduction in FGF21. These FGF changes were associated with weight gain post-FMT, to a level not exceeding the pre-rCDI baseline. Collectively, these data support the hypothesis that the restoration of gut microbial communities by FMT for rCDI is associated with an upregulated FXR-FGF pathway, and highlight the potential systemic effect of FMT.
Citation
Monaghan, T. M., Mullish, B. H., Patterson, J., Wong, G. K., Marchesi, J. R., Xu, H., Tahseen, J., & Kao, D. (2018). Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in bile acid-farnesoid X receptor-fibroblast growth factor pathway. Gut Microbes, https://doi.org/10.1080/19490976.2018.1506667
Journal Article Type | Article |
---|---|
Acceptance Date | Jul 25, 2018 |
Online Publication Date | Sep 5, 2018 |
Publication Date | Sep 5, 2018 |
Deposit Date | Jul 23, 2018 |
Publicly Available Date | Sep 6, 2019 |
Journal | Gut Microbes |
Print ISSN | 1949-0976 |
Electronic ISSN | 1949-0984 |
Publisher | Taylor and Francis |
Peer Reviewed | Peer Reviewed |
DOI | https://doi.org/10.1080/19490976.2018.1506667 |
Keywords | microbiota; fecal microbiota transplantation (FMT); recurrent Clostridium difficile infection (rCDI); bile acid metabolism; fibroblast growth factor (FGF)19 |
Public URL | https://nottingham-repository.worktribe.com/output/947614 |
Additional Information | This is an Accepted Manuscript of an article published by Taylor & Francis in Gut microbes on 05/09/2018, available online: https://www.tandfonline.com/doi/full/10.1080/19490976.2018.1506667 |
Contract Date | Jul 23, 2018 |
Files
Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in bile acid-farnesoid X receptor-fibroblast growth factor pathway.pdf
(1.1 Mb)
PDF
You might also like
New perspectives in Clostridium difficile disease pathogenesis
(2015)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search